AUGUSTA — A Maine bill that would allow an opioid-overdose antidote to be sold without a prescription is gaining support in the Legislature, but may not have enough votes to survive a veto by Gov. Paul LePage.
The Senate voted 25-8 and the House, 98-49, on Thursday to pass the bill. The measure is backed by police and health care providers. Additional votes in the Legislature will be needed to send the bill to the Republican governor, who has opposed past attempts to increase access to naloxone.
Also known by its trade name, Narcan, the antidote reverses the effects of heroin, Oxycodone and other powerful pain killers. It is not addictive and does not produce euphoria, and has become standard equipment for rescue squads around the state as Maine faces a drug epidemic.
Major drugstore chains like CVS, Walgreens and Rite Aid all plan to sell naloxone without a prescription in several states this year. The retail giant Target also will start selling it.
The bill requires pharmacists to receive training on naloxone and to provide information to customers on administering the drug as well as the availability of drug treatment.
Supporters say easing access to the drug would save lives in Maine, which saw a record 272 drug overdose deaths in 2015. But opponents say it would enable drug users to take greater risks.
“This bill is very simply about savings the lives of people who suffer from the illness of addiction so they can live another day and get treatment,” Sen….. Cathy Breen, D-Falmouth,………. said.
Sen. Anne Haskell, a Portland Democrat, said reviving a drug user gives them a second chance.
“You can’t treat someone who is not alive,” she said.
Additional votes in the House and Senate would be needed to send the bill to LePage, who has opposed past attempts to increase access to naloxone.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less